Gable Pharmaceutical (OPC) Private Limited
About Gable Pharmaceutical (OPC) Private Limited
Data last updated:
Gable Pharmaceutical (OPC) Private Limited was a one person company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 May 2017.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2017OPC317154.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Mayank Bhardwaj and Rishabh Bhardwaj (Nominee).
Its last annual general meeting (AGM) was held on 30 July 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at H – No – 176 – A G – No – 1 West Karawal Nagar Shahid Bhagat Singh, School, Delhi, India – 110094.
Company details
Contact details
Gable Pharmaceutical (OPC) Private Limited's registered office is in Delhi, Delhi.
- Registered AddressH – No – 176 – A G – No – 1 West Karawal Nagar Shahid Bhagat Singh, School, Delhi, India – 110094
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Gable Pharmaceutical (OPC) Private Limited
FY 2018 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2017-18 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Gable Pharmaceutical (OPC) Private Limited, buy the company report.
Board of directors of Gable Pharmaceutical (OPC) Private Limited
Gable Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rishabh Bhardwaj Also directs: Rischh Ventures Private Limited | Nominee | 03 May 2017 | 9 Years 5 Months | As last reported |
| Mayank Bhardwaj Also directs: Rischh Ventures Private Limited | Director | 03 May 2017 | 9 Years 5 Months | As last reported |
Legal cases
No court or tribunal cases involving Gable Pharmaceutical (OPC) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gable Pharmaceutical (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Gable Pharmaceutical (OPC) Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Gable Pharmaceutical (OPC) Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Mayank Bhardwaj was appointed as Director on 03 May 2017.
Frequently asked questions
Gable Pharmaceutical has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Gable Pharmaceutical was a company based in Delhi, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 May 2017 and is registered under CIN U51909DL2017OPC317154. The company has been struck off by the Registrar of Companies and is no longer operational.
Gable Pharmaceutical had 2 directors:
- Mayank Bhardwaj - Director
- Rishabh Bhardwaj - Nominee
The CIN (Corporate Identification Number) of Gable Pharmaceutical is U51909DL2017OPC317154. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Gable Pharmaceutical is at H – No – 176 – A G – No – 1 West Karawal Nagar Shahid Bhagat Singh, School, Delhi, India – 110094.
Gable Pharmaceutical was incorporated on 03 May 2017. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Gable Pharmaceutical on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 July 2018. Year-wise statements from FY 2018 are in the company report.
Gable Pharmaceutical operated in the pharma industry, in the pharmaceutical retailers and distributors segment. It worked in this industry before it was struck off.
Mayank Bhardwaj was appointed as Director on 03 May 2017. Rishabh Bhardwaj was appointed as Nominee on 03 May 2017.
The compliance status of Gable Pharmaceutical is active non-compliant as of 06 July 2026.